BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,011,871 | +162.1% | 1,414,215 | +247.9% | 0.01% | +300.0% |
| Q2 2023 | $12,977,757 | +10.0% | 406,444 | +5.5% | 0.00% | 0.0% |
| Q1 2023 | $11,797,886 | -17.6% | 385,300 | +5.3% | 0.00% | -50.0% |
| Q4 2022 | $14,312,774 | -26.5% | 365,962 | -10.4% | 0.00% | 0.0% |
| Q3 2022 | $19,462,000 | +123.1% | 408,532 | +81.3% | 0.00% | +33.3% |
| Q2 2022 | $8,723,000 | -57.5% | 225,332 | -37.0% | 0.00% | -25.0% |
| Q1 2022 | $20,509,000 | +17.2% | 357,918 | +63.0% | 0.00% | +33.3% |
| Q4 2021 | $17,494,000 | -44.7% | 219,529 | -39.6% | 0.00% | -50.0% |
| Q3 2021 | $31,610,000 | +73.9% | 363,292 | +157.3% | 0.01% | +50.0% |
| Q2 2021 | $18,176,000 | -20.5% | 141,212 | -50.6% | 0.00% | -20.0% |
| Q1 2021 | $22,861,000 | +167.6% | 285,617 | +173.0% | 0.01% | +150.0% |
| Q4 2020 | $8,542,000 | +1025.4% | 104,633 | +285.7% | 0.00% | – |
| Q2 2020 | $759,000 | -51.1% | 27,126 | -68.6% | 0.00% | -100.0% |
| Q1 2020 | $1,553,000 | – | 86,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |